Polaris Market Research releases its new research report on the minimal residual disease (MRD) market, which provides comprehensive insight into the current market landscape and future outlook. It discusses the major forces driving growth, including the rising global cancer burden, the shift toward precision oncology, and continuing advances in next-generation sequencing (NGS) and liquid...